# Xiamen C&D Corporation

> Xiamen C&D Corporation is a VC fund backing Health Care and Manufacturing. See 40 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Xiamen, China
- Total investments: 40
- Last investment: Mar 2026
- Lead investor: 23%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/xiamen-c&d-inc-
- Website: http://www.chinacdc.com

Xiamen C&D Corporation is a VC fund in Xiamen focused on Health Care and Manufacturing. Xiamen C&D Co., Ltd is a state-owned enterprise in Xiamen City. Founded in December 1980, after more than 30 years of innovation and transformation, the company has developed into a large industrial investment enterprise group with a registered capital of 5 billion Yuan, an annual operating income of over 220 billion Yuan and total assets ofmore than 210 billion Yuan, ranking 362th among the Global Fortune 500 companies in 2018, 112th among the top 500 Chinese companies and 49th among the top 500 Chinese service companies.From now on, their Corporation will expand the investment to existing core businesses, properly increase the investment to current emerging industries, actively carry out the capital operation on other invested enterprises, and try to invest in some new fields. Moreover, they will combine traditional industry project with high-tech projects, industrial investment with strategic investment and risk investment, and independent investment operation with joint-venture cooperation, so as to urge the formation and upgrade of the core competitiveness in key fields, realize the big increase of investment gain and the appreciation of core business brands, and promote the stable development of their Corporation.

## Contacts

5 contacts available for Xiamen C&D Corporation. Shizune tracks 1 team members at Xiamen C&D Corporation. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/xiamen-c-d-corporation?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 7 | 18% |
| Manufacturing | 7 | 18% |
| Medical | 5 | 13% |
| Pharmaceutical | 5 | 13% |
| E-Commerce | 4 | 10% |

54 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series B | 11 | 28% |
| Series A | 9 | 23% |
| Series C | 9 | 23% |
| Series E | 3 | 8% |
| Seed | 2 | 5% |

9 stages tracked in total.

### Country

| Country | Investments | Share |
| --- | --- | --- |
| China | 33 | 83% |
| Finland | 1 | 3% |
| Hong Kong | 1 | 3% |
| United States | 1 | 3% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Liming Li | Founding Director | 0 | https://shizune.co/investors/profile/liming-li |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Hugemed | Hugemed manufactures of medical devices and provides solutions in the field of endoscopy. |  | Series C | Mar 30, 2026 |  |
| Microtide Biotechnology | Microtide Biotechnology is an innovative company specializing in the field of in vivo cell therapy. The company is dedicated to advancing next-generation biomedical technologies that harness the body’s own cellular mechanisms for disease treatment, focusing on developing safe, effective, and precise therapeutic solutions to improve patient outcomesand redefine the future of regenerative medicine. | $22.5M | Series A | Feb 02, 2026 |  |
| Changsen Pharmaceutical | Changsen Pharmaceutical is a high-tech enterprise specializing in the research, development, and innovation of oncology drugs. The company is committed to advancing cancer treatment through cutting-edge scientific research, state-of-the-art technology platforms, and a strong focus on clinical efficacy and patient well-being. | $283.9M | Series B | Oct 27, 2025 |  |
| Weijian Technology | Weijian Technology is a building intelligent robotics product company for the construction industry through robots, IoT, and AI algorithms. | $16.8M | Series A | Aug 23, 2024 |  |
| Rongshujia | Rongshujia offers industry-specific system solutions for TCM clinics. Their health interventions involve holographic digitization of the human body, relying on advanced data resources and artificial intelligence algorithms. They provide AI-assisted diagnosis and treatment, health records management, authentic Chinese herbal medicine, wellnesstherapy, chronic illness treatment, and other services. |  | Series B | Mar 27, 2024 |  |
| Cencorp Automation | Cencorp Automation is a process automation solution provider. Their product portfolio includes equipment solutions for depaneling, odd-form assembly, test handling, laser marking, laser welding and final assembly to tailor-made solutions substantially improving the productivity and quality of the customers’ production. Their innovative automationsolutions increase customer production process efficiency significantly. Cencorp customers include e.g. the leading companies in car electronics, telecommunications and industrial electronics. | $14.2M | Series B | Oct 27, 2023 |  |
| Shenkepu Industry | Shenkepu Industry provides industrial process automation solutions and uses high-end process equipment. | $13.7M | Series B | Oct 27, 2023 |  |
| Supmea Automation | Supmea is a high-tech enterprise engaged in the research and development, manufacturing, sales, and service of process automation instruments. |  | Series B | Sep 01, 2023 |  |
| Meiyi Automation | Meiyi Automation is a provider of process automation instruments that engages in supply chain innovation, product research and development, manufacturing, and digital sales and services. |  | Series B | Sep 01, 2023 |  |
| Lattice Microelectronics | Lattice Microelectronics promote the design and development, module manufacturing and vehicle application of power semiconductors. |  | Series A | Jun 20, 2023 |  |

10 of 40 investments shown.

## Co-investors
- [Legend Capital](https://shizune.co/investors/profile/legend-capital) — VC Fund, 8 deals together
- [Eastern Bell Capital](https://shizune.co/investors/profile/eastern-bell-venture-capital) — VC Fund, 6 deals together
- [Qiming Venture Partners](https://shizune.co/investors/profile/qiming-venture-partners) — VC Fund, 4 deals together
- [BioVenture](https://shizune.co/investors/profile/bioventure) — VC Fund, 3 deals together
- [China Structural Reform Fund](https://shizune.co/investors/profile/china-structural-reform-fund) — VC Fund, 3 deals together
- [Dunhong Capital Management](https://shizune.co/investors/profile/dunhong-capital-management) — VC Fund, 3 deals together

## Similar investors

### Similar industry
- [Brick & Mortar Ventures](https://shizune.co/investors/profile/brick-mortar-vc) — VC Fund
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Foundamental](https://shizune.co/investors/profile/foundamental) — VC Fund

### Similar stage
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund
- [FJ Labs](https://shizune.co/investors/profile/fj-labs) — VC Fund

### Similar country
- [IDG Capital](https://shizune.co/investors/profile/idg-capital-partners) — VC Fund
- [Qiming Venture Partners](https://shizune.co/investors/profile/qiming-venture-partners) — VC Fund
- [HSG](https://shizune.co/investors/profile/sequoia-capital-china) — VC Fund

## Featured in investor lists
- [Construction VC Funds in China](https://shizune.co/investors/construction-vc-funds-china)

## FAQ

### What does Xiamen C&D Corporation invest in?

Xiamen C&D Corporation invests primarily in Health Care, Manufacturing and Medical startups, most often at Series B and Series A stage. Most of the 40 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Xiamen C&D Corporation?

Public channels for Xiamen C&D Corporation include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Xiamen C&D Corporation?

The team at Xiamen C&D Corporation includes Liming Li (Founding Director). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co